Application
TOM1L1 Antibody (C-term) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the TOM1L1 antibody detected the TOM1L1 protein (arrow).| Product Name | TOM1L1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TOM1L1; SRCASM; TOM1-like protein 1; Src-activating and signaling molecule protein; Target of Myb-like protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | SRCASM |
|---|---|
| Alternative Names | TOM1L1 SRCASM TOM1-like protein 1 Src-activating and signaling molecule protein Target of Myb-like protein 1 |
| Molecular Weight(MW) | 52989 Da |
| Function | Probable adapter protein involved in signaling pathways. Interacts with the SH2 and SH3 domains of various signaling proteins when it is phosphorylated. May promote FYN activation, possibly by disrupting intramolecular SH3-dependent interactions (By similarity) |
| Tissue Specificity | This TOM1L1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 444-474 amino acids from the C-terminal region of human TOM1L1. |
| Cellular Localization | Golgi apparatus, Golgi stack. Endosome membrane (Potential). Cytoplasm (By similarity). Membrane; Peripheral membrane protein; Cytoplasmic side (By similarity) Note=A small proportion is membrane-associated (By similarity) |
| Entrez Gene | 10040 |
|---|---|
| Nucleotide Accession | NP_005477.2 |
Application
TOM1L1 Antibody (C-term) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the TOM1L1 antibody detected the TOM1L1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
